Streetbeat News

Revenues

EVGO

EVgo Inc. (NASDAQ:EVGO) reported preliminary 2023 results, with increased utilization and an expanding charging network. The company expects to meet or exceed its 2023 financial goals. Organizational changes include streamlining functions and appointing Dennis Kish as President. Ivo Steklac and Tanvi Chaturvedi will depart the company, with Steklac serving as an advisor during the transition. The changes aim to grow the core business, improve cost structure, and accelerate growth and profitability.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 12:02 pm

NFLX

KeyBanc Capital Markets analyst Justin Patterson upgraded Netflix, Inc. (NASDAQ:NFLX) stock rating to Overweight and increased the price target from $525 to $545, anticipating a Q4 beat. Patterson forecasts Q4 revenue of $8.74 billion and EPS of $2.22, slightly above consensus estimates. He predicts 9.6 million net paid subscriber additions, higher than the consensus of 8.7 million. The analyst expects Netflix to guide to at least $9.1 billion in Q1 revenue and net adds above the previous year's level. KeyBanc raised its Q4 revenue and EPS estimates by 1% and 3%, respectively, and increased its 2023, 2024, and 2025 EPS estimates for Netflix by 1% each.

Portfolio Pulse from Shanthi Rexaline

January 17, 2024 | 12:02 pm

DTM

DT Midstream (NYSE:DTM) has been analyzed by 3 analysts, with mixed opinions ranging from bullish to bearish. The average 12-month price target is $56.33, with a high of $59.00 and a low of $53.00, reflecting a 2.03% decrease from the previous average. Analysts from Barclays, Wolfe Research, and Mizuho have provided updates, with Barclays raising its target to $59.00, Wolfe Research setting a target of $53.00, and Mizuho lowering its target to $57.00. DT Midstream operates in natural gas midstream services and has shown strong profitability with a net margin of 38.89%, but faces challenges with revenue decline, below-average ROE, and ROA.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 12:00 pm

ANSS

In the last three months, 6 analysts have provided diverse ratings on Ansys (NASDAQ:ANSS), with an average 12-month price target of $312.00, down from $338.00. Recent actions include both raised and lowered price targets and ratings, reflecting changes in market dynamics and company performance. Ansys's financials show a market cap below industry average, a revenue decline of -2.9%, a high net margin of 12.1%, but lagging ROE and ROA. The company's debt-to-equity ratio is low at 0.17.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 12:00 pm

BMY

Bristol Myers Squibb (NYSE:BMY) announced the presentation of data at the ASCO GU 2024, highlighting progress in genitourinary cancer treatments. The data includes results from 14 studies and collaborations, showcasing potential new treatment options and platforms that may transform treatment paradigms.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 12:00 pm

RXRX

Analysts have provided mixed reviews on Recursion Pharmaceuticals (NASDAQ:RXRX) over the past three months, with 3 bullish and 1 indifferent rating. The average 12-month price target is $13.75, down from $14.00, with a high of $15.00 and a low of $10.00. Recent analyst actions include maintaining and lowering ratings and price targets. Recursion Pharmaceuticals is a clinical-stage biotech company with a strong market presence but faces challenges in revenue growth, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 12:00 pm

ADTN

Adtran (NASDAQ:ADTN) has received mixed analyst ratings over the past three months, with 2 bullish and 2 indifferent ratings. The average 12-month price target is now $8.25, down 17.5% from the previous $10.00. Analysts Ryan Koontz from Needham and Mike Genovese from Rosenblatt have made recent adjustments to their ratings and price targets. Adtran's financial health shows challenges with a -20.07% revenue decline, a net margin of -26.71%, and an ROE of -9.91%. However, the company has a prudent debt-to-equity ratio of 0.34. Analysts' ratings are based on various factors including future earnings and company updates.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 12:00 pm

MANU

Manchester United has revised its FY24 revenue guidance downwards from the initial range of £650M - £680M to a new range of £635M - £665M.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 11:10 am

SBGI

Diamond Sports Group has entered into a Restructuring Support Agreement with key creditors to reorganize and emerge from Chapter 11 bankruptcy. The agreement includes over 85% of first lien, over 50% of second lien, and over 66% of unsecured bond holders. Sinclair Inc., Diamond's parent company, will pay $495 million in cash and provide support services as part of a settlement to aid Diamond's reorganization and separation from Sinclair.

Portfolio Pulse from Charles Gross

January 17, 2024 | 11:06 am

VGK

The Eurozone Core Consumer Price Index (CPI) year-over-year for December remained at 3.4%, which was in line with estimates and slightly lower than the previous value of 3.6%.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 10:11 am